Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)
И. В. Маев, А А Самсонов, Liudmila K Palgova, et al.
BMJ Open Gastroenterology (2020) Vol. 7, Iss. 1, pp. e000341-e000341
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version
Л. Б. Лазебник, Е. В. Голованова, С. В. Туркина, et al.
Experimental and Clinical Gastroenterology (2021) Vol. 1, Iss. 1, pp. 4-52
Open Access | Times Cited: 123
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies
Michail Kokkorakis, Emir Muzurović, Špela Volčanšek, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 454-499
Open Access | Times Cited: 30
The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review
Seyedeh Alia Moosavian, Thozhukat Sathyapalan, Tannaz Jamialahmadi, et al.
Bioinorganic Chemistry and Applications (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 41
Egg yolk lipids: separation, characterization, and utilization
E.D.N.S. Abeyrathne, Ki‐Chang Nam, Xi Huang, et al.
Food Science and Biotechnology (2022) Vol. 31, Iss. 10, pp. 1243-1256
Open Access | Times Cited: 33
Regression of Liver Steatosis Following Phosphatidylcholine Administration: A Review of Molecular and Metabolic Pathways Involved
Darya Osipova, К. Д. Кокорева, Л. Б. Лазебник, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 30
Polyene Phosphatidylcholine Ameliorates High Fat Diet-Induced Non-alcoholic Fatty Liver Disease via Remodeling Metabolism and Inflammation
Lu Yang, Tingting Feng, Jinxiu Zhao, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 21
1H-NMR Lipidomics, Comparing Fatty Acids and Lipids in Cow, Goat, Almond, Cashew, Soy, and Coconut Milk Using NMR and Mass Spectrometry
Brianna Williams, Sujatha Hewage, Daniel A. Alexander, et al.
Metabolites (2025) Vol. 15, Iss. 2, pp. 110-110
Open Access
UPLC-Q-TOF-MS-based unbiased serum metabolomics investigation of cholangiocarcinoma
Xiaowei Wang, Xuefeng Xu, Ran Jia, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Inês Domingues, Hafsa Yagoubi, Wunan Zhang, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 10, pp. 2917-2929
Open Access | Times Cited: 3
Liver-specific mitochondrial amidoxime–reducing component 1 (Mtarc1) knockdown protects the liver from diet-induced MASH in multiple mouse models
Yuanjun Guo, Zhengyu Gao, Edward L. LaGory, et al.
Hepatology Communications (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 3
Efficacy and safety of bicyclol for treating patients with idiosyncratic acute drug‐induced liver injury: A multicenter, randomized, phase II trial
Jieting Tang, Jin Gu, Naihui Chu, et al.
Liver International (2022) Vol. 42, Iss. 8, pp. 1803-1813
Closed Access | Times Cited: 14
Soybean polyenylphosphatidylcholine (PPC) is beneficial in liver and extrahepatic tissue injury: An update in experimental research
Ki M. Mak, Aditya C. Shekhar
The Anatomical Record (2023) Vol. 307, Iss. 6, pp. 2162-2186
Closed Access | Times Cited: 8
Agents for the treatment of fatty liver disease: focus on essential phospholipids
Asad Izziddin Dajani, A. Abu-Hammour
Drugs & Therapy Perspectives (2021) Vol. 37, Iss. 6, pp. 249-264
Open Access | Times Cited: 18
Essential phospholipids decrease apoptosis and increase membrane transport in human hepatocyte cell lines
Dominik Wupperfeld, Gert Fricker, Béatrice Bois De Fer, et al.
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Hepatoprotective agents in the management of intrahepatic cholestasis of pregnancy: current knowledge and prospects
Dan Shan, Siyu Dai, Qian Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Offspring NAFLD liver phospholipid profiles are differentially programmed by maternal high-fat diet and maternal one carbon supplement
Hui Peng, Jiangyuan Li, Huiting Xu, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 111, pp. 109187-109187
Open Access | Times Cited: 10
Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observational Studies
В. Т. Ивашкин, M. V. Maevskaya, Е. Н. Широкова, et al.
Drugs - Real World Outcomes (2021) Vol. 8, Iss. 3, pp. 369-382
Open Access | Times Cited: 13
Healthcare practitioners’ diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey
Marek Hartleb, Agnieszka Mastalerz–Migas, Piotr Kowalski, et al.
European Journal of Gastroenterology & Hepatology (2021) Vol. 34, Iss. 4, pp. 426-434
Open Access | Times Cited: 12
Non-alcoholic fatty liver disease: a current challenge of interdisciplinary research
Elena V. Biryukova
Meditsinskiy sovet = Medical Council (2024), Iss. 6, pp. 72-80
Open Access | Times Cited: 1
Essential phospholipids impact cytokine secretion and alter lipid-metabolizing enzymes in human hepatocyte cell lines
Dominik Wupperfeld, Gert Fricker, Béatrice Bois De Fer, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 3, pp. 572-584
Open Access | Times Cited: 1
The Primacy of Adipose Tissue Gene Expression and Plasma Lipidome in Cardiometabolic Disease in Persons With HIV
Samuel S. Bailin, Siyuan Ma, Andrew Perry, et al.
The Journal of Infectious Diseases (2024) Vol. 231, Iss. 2, pp. e407-e418
Open Access | Times Cited: 1
Circulating metabolites as a concept beyond tumor biology determining disease recurrence after resection of colorectal liver metastasis
Jan Philipp Jonas, Hubert Hackl, David Pereyra, et al.
HPB (2021) Vol. 24, Iss. 1, pp. 116-129
Open Access | Times Cited: 7
iTRAQ-based quantitative proteomics analysis of the effect of ACT001 on non-alcoholic steatohepatitis in mice
Hui Zhou, Bin Niu, Xue Wu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Effect of essential phospholipids on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity: study protocol of a randomized, double-blind, phase IV clinical trial
Norbert Stefan, Marek Hartleb, Branko Popović, et al.
Trials (2024) Vol. 25, Iss. 1
Open Access
Silencing of Hepatic AATF Ameliorates Metabolic Dysfunction Associated Steatohepatitis by Promoting Fatty Acid β-Oxidation in Experimental models
Akshatha N. Srinivas, Diwakar Suresh, M. Moorthy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top